• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    TradeUP (UPTD) Stock is Up: What's Going On?

    9/21/23 11:08:12 AM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $UPTD alert in real time by email

    TradeUP Acquisition Corp (NASDAQ:UPTD) shares are trading higher Thursday. The company has entered into subscription agreements in connection with the closing of its proposed business combination transactions, according to an SEC filing. 

    What To Know:

    According to the SEC filing, TradeUP entered into subscription agreements with Lianhe World Limited and Plentiful Limited in connection with the closing of its planned business combination transaction with Estrella Biopharma, Inc. 

    Lianhe World Limited and Plentiful Limited will each purchase $5,000,000 in shares of the combined company priced at $10 per share. 

    The filing also stated that the combined company's first day of trading is anticipated in October 2023. 

    Shares of UPTD are moving higher on heavy trading volume. According to data from Benzinga Pro, more than 2.25 million shares have already been traded in the session, compared to the stock's 100-day average of just over 348 thousand shares.

    UpTrade could be considered as a possible short-squeeze candidate due to the stock's high short-interest and low float of less than 900 thousand shares.

    Related News: What's Going On With Avinger Inc. Stock Today?

    UPTD Price Action: According to Benzinga Pro, TradeUP shares are up 42% at $17.15 at the time of publication.

    Image: fietzfotos from Pixabay

    Get the next $UPTD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UPTD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $UPTD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    TradeUP Acquisition Corp. and Estrella Biopharma, Inc. Announce Completion of Business Combination

    Estrella to Begin Trading on NASDAQ Under the Ticker Symbols "ESLA" and "ESLAW" Beginning October 2, 2023 NEW YORK, Sept. 29, 2023 /PRNewswire/ -- Estrella Immunopharma, Inc., formerly known as TradeUP Acquisition Corp. ("UPTD") (NASDAQ:UPTD, UPTDW, UPTDU))), today announced the successful closing of its business combination with Estrella Biopharma, Inc. ("Estrella"), a preclinical-stage biopharmaceutical company developing T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.  The resulting combined company will operate under the name Estrella Immunopharma, Inc. and will be led by Estrella Founder and CEO Dr. Cheng Liu. The com

    9/29/23 10:34:00 AM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination

    NEW YORK, Sept. 18, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from September 19, 2023 to October 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $37,432.70 (the "Monthly Extension Fee"), representing $0.05 per Remaining Share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biop

    9/18/23 5:00:00 PM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination

    NEW YORK, Aug. 18, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ:UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination from August 19, 2023 to September 19, 2023, for each public share that is not redeemed by the Company's stockholders in connection with such extension (collectively, the "Remaining Shares", each, a "Remaining Share"), the Company has deposited into its trust account (the "Trust Account") an aggregate of $37,432.70 (the "Monthly Extension Fee"), representing $0.05 per Remaining Share of the Company. The payment for such Monthly Extension Fee was made by Estrella Biophar

    8/18/23 4:30:00 PM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $UPTD
    SEC Filings

    View All

    SEC Form 10-Q filed by TradeUP Acquisition Corp.

    10-Q - Estrella Immunopharma, Inc. (0001844417) (Filer)

    2/14/24 5:28:53 PM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 424B3 filed by TradeUP Acquisition Corp.

    424B3 - Estrella Immunopharma, Inc. (0001844417) (Filer)

    2/12/24 5:02:06 PM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    TradeUP Acquisition Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - Estrella Immunopharma, Inc. (0001844417) (Filer)

    2/2/24 8:30:07 AM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $UPTD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Xu Jiandong claimed ownership of 264,388 shares (SEC Form 3)

    3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

    10/10/23 4:18:19 PM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Roberts Marsha

    3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

    10/10/23 4:17:50 PM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Xu Pei

    3 - Estrella Immunopharma, Inc. (0001844417) (Issuer)

    10/10/23 4:17:25 PM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $UPTD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by TradeUP Acquisition Corp.

    SC 13D - Estrella Immunopharma, Inc. (0001844417) (Subject)

    10/27/23 7:27:00 PM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by TradeUP Acquisition Corp. (Amendment)

    SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

    3/10/23 4:04:07 PM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by TradeUP Acquisition Corp. (Amendment)

    SC 13G/A - TradeUP Acquisition Corp. (0001844417) (Subject)

    2/14/23 4:49:44 PM ET
    $UPTD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care